Organometallic Compounds
Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 5 MG
Gemigliptin tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.
- Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- Exhibits potent anti-glycation properties
- Useful for research of advanced glycation end products (AGE)-related diabetic complications
Selleck Chemical LLC NVR 3-778
NVR 3-778 belonging to the SBA (sulfamoylbenzamide) class is a first-in-Class and oral bioavailable HBV CAM (capsid assembly modulator) NVR 3-778 exhibits anti-HBV activity
TARGETMOL CHEMICALS INC Tylosin tartrate 200MG
Also available in 1 mL, 25 mg, 50 mg, 100 mg, 500 mg and bulk. Please contact Fisher for quotes. Tylosin tartrate, a macrolide antibiotic, is approved for the control of mycoplasmosis in poultry. Purity 99.16%
Medchemexpress LLC Acetoacetic acid lithium | 3483-11-2 | 98.0% | 108.02 | 50 MG
Acetoacetic acid lithium | 3483-11-2 | 98.0% | 108.02 | 50 MG
Apexbio Technology LLC Epidermal growth factor receptor (994-1002) acetyl/amide 25mg
Epidermal growth factor receptor 994-1002 acetyl amide is a peptide fragment derived from the epidermal growth factor receptor (EGFR) acetylated and amidated at its termini It is designed to serve as a tool for investigating receptor-ligand interactions and receptor activation mechanisms associated with EGFR-mediated signaling pathways Epidermal growth factor receptor 994-1002 acetyl amide acts by enabling the study of EGFR activation particularly receptor dimerization and autophosphorylation processes Based on its biological characteristics this peptide has research potential in evaluating therapeutic strategies targeting EGFR-mediated oncogenesis including studies of proliferation differentiation migration and survival in malignancies such as glioblastoma and lung cancers
Apexbio Technology LLC NVR 3-778 1445790-55-5 10mg
NVR 3-778 (CAS 1445790-55-5) is a small-molecule modulator targeting the hepatitis B virus (HBV) core protein It is designed to interfere with HBV capsid assembly thereby inhibiting viral genome encapsidation and replication NVR 3-778 exerts its biological activity primarily by disrupting capsid formation and reducing viral replication In in vitro studies NVR 3-778 demonstrates antiviral inhibition with a half-maximal inhibitory concentration (IC50) reported in the low micromolar range Based on these pharmacological properties NVR 3-778 holds research potential in the investigation of HBV biology and the development of alternative therapeutic approaches for chronic hepatitis B infection
